- Filed
- Feb 10, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2020 · Feb 3, 2020 | 43.24M sh |
| Shares Diluted | Q3 2020 · Dec 31, 2019 | 45.29M sh |
| Shares Diluted | Q3 2020 · Dec 31, 2019 | 45.17M sh |
| Shares Diluted | Q3 2020 · Dec 31, 2018 | 38.73M sh |
| Shares Diluted | Q3 2020 · Dec 31, 2018 | 38.81M sh |
| Capex | Q3 2020 · Dec 31, 2019 | $495K |
| Capex | Q3 2020 · Dec 31, 2018 | $951K |
| Operating Cash Flow | Q3 2020 · Dec 31, 2019 | $9.77M |
| Operating Cash Flow | Q3 2020 · Dec 31, 2018 | $12.76M |
| Short Term Investments | Q3 2020 · Dec 31, 2019 | $25.54M |
| Short Term Investments | Q3 2020 · Mar 31, 2019 | $28.11M |
| Cash And Equivalents | Q3 2020 · Dec 31, 2019 | $20M |
| Cash And Equivalents | Q3 2020 · Mar 31, 2019 | $11.33M |
| Stockholders Equity | Q3 2020 · Dec 31, 2019 | $105.04M |
| Stockholders Equity | Q3 2020 · Mar 31, 2019 | $95.34M |
| Current Liabilities | Q3 2020 · Dec 31, 2019 | $49.82M |
| Current Liabilities | Q3 2020 · Mar 31, 2019 | $48.63M |
| Total Liabilities | Q3 2020 · Dec 31, 2019 | $56.03M |
| Total Liabilities | Q3 2020 · Mar 31, 2019 | $52.78M |
| Current Assets | Q3 2020 · Dec 31, 2019 | $100.4M |
| Current Assets | Q3 2020 · Mar 31, 2019 | $90.36M |
| Total Assets | Q3 2020 · Dec 31, 2019 | $161.08M |
| Total Assets | Q3 2020 · Mar 31, 2019 | $149.35M |
| Eps Diluted | Q3 2020 · Dec 31, 2019 | $0.09 |
| Eps Diluted | Q3 2020 · Dec 31, 2019 | $0.14 |
| Eps Diluted restated | Q3 2020 · Dec 31, 2018 | $0.04 |
| Eps Diluted restated | Q3 2020 · Dec 31, 2018 | $0.14 |
| Eps Basic | Q3 2020 · Dec 31, 2019 | $0.09 |
| Eps Basic | Q3 2020 · Dec 31, 2019 | $0.14 |
| Eps Basic | Q3 2020 · Dec 31, 2018 | $0.05 |
| Eps Basic restated | Q3 2020 · Dec 31, 2018 | $0.15 |
| Sga Expense | Q3 2020 · Dec 31, 2019 | $10.03M |
| Sga Expense | Q3 2020 · Dec 31, 2019 | $31.73M |
| Sga Expense restated | Q3 2020 · Dec 31, 2018 | $10.3M |
| Sga Expense restated | Q3 2020 · Dec 31, 2018 | $29.48M |
| Rd Expense | Q3 2020 · Dec 31, 2019 | $4.71M |
| Rd Expense | Q3 2020 · Dec 31, 2019 | $14.64M |
| Rd Expense restated | Q3 2020 · Dec 31, 2018 | $4.85M |
| Rd Expense restated | Q3 2020 · Dec 31, 2018 | $14.38M |
| Net Income | Q3 2020 · Dec 31, 2019 | $3.88M |
| Net Income | Q3 2020 · Dec 31, 2019 | $6.07M |
| Net Income restated | Q3 2020 · Dec 31, 2018 | $1.73M |
| Net Income restated | Q3 2020 · Dec 31, 2018 | $5.45M |
| Operating Income | Q3 2020 · Dec 31, 2019 | $3.11M |
| Operating Income | Q3 2020 · Dec 31, 2019 | $7.04M |
| Operating Income restated | Q3 2020 · Dec 31, 2018 | $2.37M |
| Operating Income restated | Q3 2020 · Dec 31, 2018 | $6.91M |
| Gross Profit | Q3 2020 · Dec 31, 2019 | $17.85M |
| Gross Profit | Q3 2020 · Dec 31, 2019 | $53.4M |
| Gross Profit restated | Q3 2020 · Dec 31, 2018 | $17.53M |
| Gross Profit restated | Q3 2020 · Dec 31, 2018 | $50.78M |